Retinal Prostheses: Engineering and Clinical Perspectives for Vision Restoration.

flexible electronic devices flexible sensors human–machine interface implantable electronic devices ophthalmology retinal disease retinal prosthesis vision restoration

Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
21 Jun 2023
Historique:
received: 20 04 2023
revised: 04 06 2023
accepted: 19 06 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

A retinal prosthesis, also known as a bionic eye, is a device that can be implanted to partially restore vision in patients with retinal diseases that have resulted in the loss of photoreceptors (e.g., age-related macular degeneration and retinitis pigmentosa). Recently, there have been major breakthroughs in retinal prosthesis technology, with the creation of numerous types of implants, including epiretinal, subretinal, and suprachoroidal sensors. These devices can stimulate the remaining cells in the retina with electric signals to create a visual sensation. A literature review of the pre-clinical and clinical studies published between 2017 and 2023 is conducted. This narrative review delves into the retinal anatomy, physiology, pathology, and principles underlying electronic retinal prostheses. Engineering aspects are explored, including electrode-retina alignment, electrode size and material, charge density, resolution limits, spatial selectivity, and bidirectional closed-loop systems. This article also discusses clinical aspects, focusing on safety, adverse events, visual function, outcomes, and the importance of rehabilitation programs. Moreover, there is ongoing debate over whether implantable retinal devices still offer a promising approach for the treatment of retinal diseases, considering the recent emergence of cell-based and gene-based therapies as well as optogenetics. This review compares retinal prostheses with these alternative therapies, providing a balanced perspective on their advantages and limitations. The recent advancements in retinal prosthesis technology are also outlined, emphasizing progress in engineering and the outlook of retinal prostheses. While acknowledging the challenges and complexities of the technology, this article highlights the significant potential of retinal prostheses for vision restoration in individuals with retinal diseases and calls for continued research and development to refine and enhance their performance, ultimately improving patient outcomes and quality of life.

Identifiants

pubmed: 37447632
pii: s23135782
doi: 10.3390/s23135782
pmc: PMC10347280
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS One. 2021 Feb 10;16(2):e0229189
pubmed: 33566851
Sci Rep. 2020 Nov 16;10(1):19836
pubmed: 33199768
Biomed Eng Online. 2019 Aug 1;18(1):86
pubmed: 31370902
Nanoscale. 2019 Jul 18;11(28):13213-13218
pubmed: 31184360
Int J Mol Sci. 2022 Apr 28;23(9):
pubmed: 35563274
Biomed Mater Eng. 2011;21(2):83-97
pubmed: 21654065
Vision Res. 2021 May;182:58-68
pubmed: 33607599
J Neural Eng. 2022 Oct 14;19(5):
pubmed: 36174540
Neural Netw. 2023 Jul;164:357-368
pubmed: 37167749
Front Neurosci. 2018 Apr 24;12:277
pubmed: 29740278
J Neural Eng. 2021 Feb 25;18(2):
pubmed: 33339020
J Neural Eng. 2022 Mar 29;19(2):
pubmed: 35240583
Nat Neurosci. 2008 Jun;11(6):667-75
pubmed: 18432197
Acta Ophthalmol. 2018 Mar;96(2):e180-e188
pubmed: 29098796
PLoS One. 2014 Dec 18;9(12):e115239
pubmed: 25521292
Front Neurosci. 2021 Mar 04;15:615256
pubmed: 33746697
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:4482-4486
pubmed: 34892214
Transl Vis Sci Technol. 2021 Aug 12;10(10):12
pubmed: 34581770
Sensors (Basel). 2019 Jan 28;19(3):
pubmed: 30696016
Semin Ophthalmol. 2016;31(1-2):25-9
pubmed: 26959126
Nat Commun. 2022 Jan 26;13(1):513
pubmed: 35082313
Ophthalmol Retina. 2020 Jun;4(6):613-619
pubmed: 31937474
Front Cell Neurosci. 2023 Feb 06;17:1115703
pubmed: 36814867
IEEE Trans Biomed Eng. 2004 Jun;51(6):896-904
pubmed: 15188856
Ophthalmology. 2016 Oct;123(10):2248-54
pubmed: 27453256
J Neural Eng. 2021 Aug 24;18(4):
pubmed: 34359062
J Neural Eng. 2020 Jun 12;17(3):035005
pubmed: 32357356
J Neural Eng. 2022 Sep 13;19(5):
pubmed: 36044878
J Neurosci Methods. 2022 Jan 1;365:109388
pubmed: 34678387
J Neural Eng. 2022 Aug 18;19(4):
pubmed: 35917811
PLoS One. 2009 Nov 05;4(11):e7679
pubmed: 19893752
Clin Ophthalmol. 2018 Jun 13;12:1089-1097
pubmed: 29942114
Sci Adv. 2017 Mar 03;3(3):e1600448
pubmed: 28275726
Adv Nanobiomed Res. 2021 Jul;1(7):2000092
pubmed: 34746928
JAMA Ophthalmol. 2019 Aug 01;137(8):896-902
pubmed: 31145440
J Ophthalmol. 2012;2012:397178
pubmed: 23133741
Mater Today Bio. 2022 Apr 05;14:100253
pubmed: 35464741
Invest Ophthalmol Vis Sci. 2022 Oct 3;63(11):11
pubmed: 36251317
Stem Cell Rev Rep. 2012 Jun;8(2):329-42
pubmed: 21881832
Gene Ther. 2020 Feb;27(1-2):27-39
pubmed: 31243393
Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:6769-72
pubmed: 21095836
Clin Exp Optom. 2015 Jul;98(4):342-7
pubmed: 25675964
Sci Transl Med. 2019 Jan 16;11(475):
pubmed: 30651323
Nat Photonics. 2012 Jun 1;6(6):391-397
pubmed: 23049619
Am J Reprod Immunol. 2012 Jan;67(1):1-8
pubmed: 21951555
Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):9
pubmed: 32639552
IEEE Trans Neural Syst Rehabil Eng. 2021;29:300-309
pubmed: 33395394
Conf Proc IEEE Eng Med Biol Soc. 2005;2005:7373-5
pubmed: 17281984
Transplantation. 2010 Apr 27;89(8):911-9
pubmed: 20164818
Int J Biomed Imaging. 2018 Mar 14;2018:3198342
pubmed: 29731769
Nat Neurosci. 2015 Sep;18(9):1213-25
pubmed: 26308982
Micromachines (Basel). 2020 Apr 09;11(4):
pubmed: 32283779
Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):12803-12808
pubmed: 29138314
Transl Vis Sci Technol. 2021 Aug 12;10(10):7
pubmed: 34383875
Nat Mater. 2019 May;18(5):510-517
pubmed: 30804509
J Neural Eng. 2023 Feb 15;20(1):
pubmed: 36634357
Front Neurosci. 2023 May 18;17:1147729
pubmed: 37274203
Front Bioeng Biotechnol. 2021 Jan 13;8:582713
pubmed: 33520951
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):1882-7
pubmed: 20133836
J Neural Eng. 2022 Jun 08;19(3):
pubmed: 35609556
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):792-802
pubmed: 29392324
Acta Ophthalmol. 2021 Nov;99(7):e1212-e1221
pubmed: 33354943
Surv Ophthalmol. 2014 Mar-Apr;59(2):134-65
pubmed: 24417953
J Neural Eng. 2021 Dec 15;18(6):
pubmed: 34826830
Front Neurosci. 2022 Sep 30;16:1010445
pubmed: 36248640
Pharm Res. 2019 Jan 7;36(2):34
pubmed: 30617669
Bioconjug Chem. 2014 Sep 17;25(9):1609-19
pubmed: 25117569
Front Neurosci. 2017 Aug 23;11:445
pubmed: 28878616
J Neural Eng. 2022 Jun 06;19(3):
pubmed: 35561665
Hum Mol Genet. 2019 Oct 1;28(R1):R108-R118
pubmed: 31238338
Biomaterials. 2008 Aug-Sep;29(24-25):3393-9
pubmed: 18501423
Vis Neurosci. 2014 Sep;31(4-5):345-54
pubmed: 25100257
J Neural Eng. 2019 Apr;16(2):026017
pubmed: 30560810
Front Neurosci. 2017 Nov 14;11:620
pubmed: 29184478
Proc Biol Sci. 2011 May 22;278(1711):1489-97
pubmed: 21047851
J Neural Eng. 2019 Aug 21;16(5):056016
pubmed: 31357188
Sci Rep. 2021 Mar 4;11(1):5177
pubmed: 33664347
Stem Cell Reports. 2017 Jan 10;8(1):69-83
pubmed: 28076757
Ophthalmology. 2018 Mar;125(3):432-443
pubmed: 29110946
IEEE Trans Neural Syst Rehabil Eng. 2021;29:2733-2741
pubmed: 34941514
J Neural Eng. 2022 May 27;19(3):
pubmed: 35523152
Nat Commun. 2018 Mar 8;9(1):992
pubmed: 29520006
Ther Adv Ophthalmol. 2019 Jan 17;11:2515841418817501
pubmed: 30729233
Ophthalmology. 2021 Mar;128(3):453-462
pubmed: 32858064
Micromachines (Basel). 2020 Apr 29;11(5):
pubmed: 32365472
Sci Transl Med. 2018 Apr 4;10(435):
pubmed: 29618560
Front Neurosci. 2022 Feb 25;16:829323
pubmed: 35281487
Cell Rep. 2022 Jul 12;40(2):111040
pubmed: 35830791
Front Neurosci. 2020 Mar 26;14:262
pubmed: 32292328
Chem Commun (Camb). 2011 Oct 7;47(37):10182-8
pubmed: 21776531
IEEE Trans Neural Syst Rehabil Eng. 2021;29:2292-2298
pubmed: 34705653
Sci Transl Med. 2015 Dec 16;7(318):318ra203
pubmed: 26676610
J Neurosci. 2014 Apr 2;34(14):4871-81
pubmed: 24695706
Nat Biomed Eng. 2020 Feb;4(2):137-138
pubmed: 32051579
J Neural Eng. 2022 Sep 27;19(5):
pubmed: 36055219
Nat Commun. 2022 Jun 27;13(1):3678
pubmed: 35760775
Nanomaterials (Basel). 2022 Oct 01;12(19):
pubmed: 36234573
Biomaterials. 2017 Jan;112:108-121
pubmed: 27760395
J Neural Eng. 2022 Dec 19;19(6):
pubmed: 36533865
Vision Res. 2015 Jun;111(Pt B):149-60
pubmed: 25812924
Transl Vis Sci Technol. 2022 Sep 1;11(9):4
pubmed: 36066322
Nat Commun. 2022 Nov 4;13(1):6627
pubmed: 36333326
Exp Eye Res. 2016 Sep;150:149-65
pubmed: 27020758
Nat Biomed Eng. 2023 Apr;7(4):387-404
pubmed: 35102278
Nat Commun. 2018 Mar 6;9(1):786
pubmed: 29511183
Ophthalmology. 2020 Aug;127(8):1097-1104
pubmed: 32249038
Mil Med Res. 2019 Jun 5;6(1):19
pubmed: 31167653
Biomaterials. 2005 Jun;26(17):3511-9
pubmed: 15621241
J Cell Biochem. 2017 Jul;118(7):1699-1711
pubmed: 27935095
Cell Stem Cell. 2018 Jun 01;22(6):834-849
pubmed: 29859174
Nat Nanotechnol. 2008 Jul;3(7):434-9
pubmed: 18654569
Int J Mol Sci. 2022 Sep 29;23(19):
pubmed: 36232782
J Neural Eng. 2019 Apr;16(2):025001
pubmed: 30523958
Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4167-73
pubmed: 15505071
Prog Retin Eye Res. 2014 Nov;43:108-28
pubmed: 25124745
Biomed Opt Express. 2021 Sep 30;12(10):6651-6659
pubmed: 34745762
Eur J Ophthalmol. 2021 May;31(3):920-931
pubmed: 33736500
Ophthalmol Retina. 2020 Mar;4(3):264-273
pubmed: 31786135
Semin Ophthalmol. 2021 May 19;36(4):168-175
pubmed: 33734937
IEEE Trans Neural Syst Rehabil Eng. 2021;29:2496-2502
pubmed: 34784278
Transl Vis Sci Technol. 2020 Dec 18;9(13):31
pubmed: 33384885
J Neural Eng. 2018 Jun;15(3):036011
pubmed: 29388561
Ophthalmology. 2011 Nov;118(11):2227-37
pubmed: 22047893
J Neural Eng. 2021 Mar 16;18(3):
pubmed: 33592588
J Neurophysiol. 2017 Sep 1;118(3):1457-1471
pubmed: 28566464
Ophthalmology. 2019 Apr;126(4):637-639
pubmed: 30591229
Micromachines (Basel). 2020 May 24;11(5):
pubmed: 32456341
Biochem Biophys Res Commun. 2020 Jun 25;527(2):325-330
pubmed: 31982136
Turk J Ophthalmol. 2019 Sep 03;49(4):213-219
pubmed: 31486609
J Neural Eng. 2022 Nov 29;19(6):
pubmed: 36368033
Sci Rep. 2019 Jul 23;9(1):10657
pubmed: 31337815
J Neural Eng. 2019 Dec 23;17(1):016018
pubmed: 31665704

Auteurs

Kevin Y Wu (KY)

Department of Surgery, Division of Ophthalmology, University of Sherbrooke, Sherbrooke, QC J1G 2E8, Canada.

Mina Mina (M)

Department of Mechanical and Manufacturing Engineering, University of Calgary, Calgary, AB T2N 1N4, Canada.

Jean-Yves Sahyoun (JY)

Faculty of Medicine, University of Montreal, Montreal, QC H3T 1J4, Canada.

Ananda Kalevar (A)

Department of Surgery, Division of Ophthalmology, University of Sherbrooke, Sherbrooke, QC J1G 2E8, Canada.

Simon D Tran (SD)

Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, QC H3A 1G1, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH